Scott-Levin Reports: Managed Care Loves Generic Prozac.Business Editors/Health & Medical Writers NEWTOWN, Pa.--(BW HealthWire)--Feb. 14, 2002 Almost as soon as a generic form of Prozac became available, it was covered by 91 percent of managed care formularies, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the Fall 2001 Managed Care Formulary formulary /for·mu·lary/ (for´mu-lar?e) a collection of recipes, formulas, and prescriptions. National Formulary see under N. for·mu·lar·y n. Drug Audit from Scott-Levin, a Quintiles Quintiles Transnational Corp. is a contract research organization which serves the pharmaceutical, biotechnology and healthcare industries. History Quintiles was founded in 1982 by Dennis Gillings and as of 2007 it has 18,000 employees. Transnational company (Nasdaq: QTRN). This semiannual audit measures formulary acceptance of individual drugs in more than 40 therapeutic classes. In addition to formulary designation, the audit tracks preferred and contracting status, restrictions, prior authorization prior authorization, n See predetermination. prior authorization Health insurance A cost containment measure that provides full payment of health benefits only if the hospitalization or medical treatment has been and third-tier status. Fluoxetine fluoxetine /flu·ox·e·tine/ (floo-ok´se-ten) a selective serotonin reuptake inhibitor used as the hydrochloride salt in the treatment of depression, obsessive-compulsive disorder, bulimia nervosa, and premenstrual dysphoric disorder. , the generic version of the blockbuster antidepressant antidepressant, any of a wide range of drugs used to treat psychic depression. They are given to elevate mood, counter suicidal thoughts, and increase the effectiveness of psychotherapy. Prozac, hit pharmacy shelves in July 2001. Not surprisingly, branded Prozac's formulary status dropped to 41 percent from 80 percent after fluoxetine was launched.
Antidepressants
On Formulary - HMOs/PBMs
----------------------------------------------------------------------
Drug Manufacturer Spring 2001 Fall 2001
----------------------------------------------------------------------
Celexa Forest 84% 86%
---------------------------------------------------------------------
Effexor Wyeth-Ayerst 92% 91%
---------------------------------------------------------------------
Effexor XR Wyeth-Ayerst 94% 95%
---------------------------------------------------------------------
Fluoxetine Generic NA 91%
---------------------------------------------------------------------
Luvox Solvay 26% 28%
---------------------------------------------------------------------
Paxil GlaxoSmithKline 98% 97%
---------------------------------------------------------------------
Prozac Eli Lilly 80% 41%
---------------------------------------------------------------------
Prozac Weekly Eli Lilly NA 28%
---------------------------------------------------------------------
Sarafem Eli Lilly 26% 21%
---------------------------------------------------------------------
Zoloft Pfizer 92% 91%
---------------------------------------------------------------------
Source: Scott-Levin's Fall 2001 Managed Care Formulary Drug Audit
The co-pay difference for consumers between a generic drug generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name. and nonformulary brand-name drug Noun 1. brand-name drug - a drug that has a trade name and is protected by a patent (can be produced and sold only by the company holding the patent) proprietary drug drug - a substance that is used as a medicine or narcotic is significant, averaging more than $24 per prescription, according to Scott-Levin. The average co-pay for a first-tier drug (typically a generic) is $7.70, versus $16.35 for a second-tier drug (typically a branded formulary drug) and $31.89 for a third-tier drug (typically a nonformulary branded drug). About the Audit Scott-Levin's Managed Care Formulary Drug Audit is a semiannual study of the formularies and related prescribing controls at the country's largest, most influential managed care organizations for more than 40 therapeutic classes of drugs. The fall 2001 pharmacy executive panel represented an estimated 67 percent of all U.S. managed care subscribers whose drug benefits are controlled by formularies. About Scott-Levin Scott-Levin, a part of Quintiles Informatics Same as information technology and information systems. The term is more widely used in Europe. , provides consulting services to more than 100 U.S. and international pharmaceutical clients. These services monitor key areas such as product promotion, industry trends, retail pharmacy activity, market performance, managed care and government affairs. Scott-Levin's market research audits and strategic studies cover detailing, meetings and events, direct-to-consumer advertising direct-to-consumer advertising Drug industry The use of mass media–eg, TV, magazines, newspapers, to publicly promote drugs, medical devices or other products which, by law, require a prescription, which targets consumers, with the intent of having a Pt , journal advertising, and other media. Taken together, Scott-Levin products can give clients the most accurate possible picture of total pharmaceutical promotion. Quintiles Transnational Corp. is the world's leading provider of information, technology and services to bring new medicines to patients faster and improve health care. Headquartered near Research Triangle Park Research Triangle Park, research, business, medical, and educational complex situated in central North Carolina. It has an area of 6,900 acres (2,795 hectares) and is 8 × 2 mi (13 × 3 km) in size. Named for the triangle formed by Duke Univ. , N.C., Quintiles is a member of the S&P 500 and Fortune 1000. For more information, visit the company's Web site at www.quintiles.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion